Wnt signaling in B-cell neoplasia

[1]  S. Rudikoff,et al.  Insulinlike growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk. , 2002, Blood.

[2]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[3]  Yoichi Kato,et al.  Wnt/Frizzled Activation of Rho Regulates Vertebrate Gastrulation and Requires a Novel Formin Homology Protein Daam1 , 2001, Cell.

[4]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[5]  H. Niwa,et al.  Wnt Signaling Regulates Hemopoiesis Through Stromal Cells1 , 2001, The Journal of Immunology.

[6]  Yan Li,et al.  LDL-receptor-related protein 6 is a receptor for Dickkopf proteins , 2001, Nature.

[7]  L. Luo,et al.  Drosophila Rho-Associated Kinase (Drok) Links Frizzled-Mediated Planar Cell Polarity Signaling to the Actin Cytoskeleton , 2001, Cell.

[8]  C. Eisenberg,et al.  WNT signaling modulates the diversification of hematopoietic cells. , 2000, Blood.

[9]  B. Klein,et al.  Insulin‐like growth factor induces the survival and proliferation of myeloma cells through an interleukin‐6‐independent transduction pathway , 2000, British journal of haematology.

[10]  William C. Skarnes,et al.  An LDL-receptor-related protein mediates Wnt signalling in mice , 2000, Nature.

[11]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[12]  Yoichi Kato,et al.  LDL-receptor-related proteins in Wnt signal transduction , 2000, Nature.

[13]  S. Rudikoff,et al.  Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo , 2000, Oncogene.

[14]  R Grosschedl,et al.  Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. , 2000, Immunity.

[15]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[16]  Randall T Moon,et al.  Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.

[17]  J. Downing,et al.  Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Ishimoto,et al.  Characterization of Mouse Dishevelled (Dvl) Proteins in Wnt/Wingless Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[19]  Fumiaki Ito,et al.  Cytoskeletal reorganization by soluble Wnt‐3a protein signalling , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[20]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[21]  M. Semënov,et al.  Human dishevelled genes constitute a DHR-containing multigene family. , 1997, Genomics.

[22]  H Clevers,et al.  Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties , 1996, Molecular and cellular biology.

[23]  B. Klein,et al.  Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments. , 1995, Blood.

[24]  S. Rudikoff,et al.  Interleukin 6 is essential for in vivo development of B lineage neoplasms , 1995, The Journal of experimental medicine.

[25]  B. Klein,et al.  Mechanisms of bone lesions in multiple myeloma. , 1992, Hematology/oncology clinics of North America.

[26]  G. Gaidano,et al.  Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma , 1989, The Journal of experimental medicine.